What Is the Natural History of Resolution of Nosocomial Pneumonia?

Carlos M. Luna; Michael S. Niederman

doi:10.1055/s-2002-35718

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2002; 23(5): 471-480
DOI: 10.1055/s-2002-35718

What Is the Natural History of Resolution of Nosocomial Pneumonia?

Carlos M. Luna¹ , Michael S. Niederman^2,3

¹Pulmonary and Critical Care Divisions, Department of Medicine, Hospital de Clínicas ``José de San Martín,'' Universidad de Buenos Aires
²Winthrop-University Hospital, Mineola, New York
³Department of Medicine, SUNY at Stony Brook, New York

Abstract

ABSTRACT

Little is known about the natural history of resolution of nosocomial pneumonia, and thus it is likely that we are not always using the optimal duration of therapy in all patients. For some patients, with few risk factors for a poor outcome, and infection with easily treated pathogens, we can probably treat with a more abbreviated course of therapy than is commonly used. For other patients with risk factors for a poor outcome, and infection with ``high risk'' pathogens such as Pseudomonas aeruginosa, we may need longer durations of therapy. We review the clinical and microbiological definitions of resolution, including improvement, delayed resolution, relapse, or recurrent infection. There are also microbiological end points for resoution including eradication, persistence, and superinfection. The clinical parameters that affect resolution are patient related, microbiological, and treatment related, and these factors are summarized here. Currently, the time course of resolution is being defined using clinical end points such as the clinical pulmonary infection score (CPIS) and microbiological end points such as quantitative cultures of respiratory secretions. The hope for the future is to be able to identify whether the clinical response is adequate, at the earliest posible time point. This may allow for interventions to help the nonresponding patient, or shorten the duration of therapy in the responding patient.

KEYWORDS

Nosocomial pneumonia - Pseudomonas aeruginosa, ventilator-associated pneumonia - antibiotic resistance - pneumonia resolution

Full Text

References

REFERENCES

1 Vincent J L, Bihari D J, Suter P M. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA . 1995; 274 639-644
2 Heyland D K, Cook D J, Griffith L, Keenan S P, Brun-Buisson C. The attributable morbidity and mortality of ventilator associated pneumonia in the critically ill patient. Am J Respir Crit Care Med . 1999; 159 1249-1256
3 Hernandez C, el-Ebiary M, Gonzalez J, de la Bellacasa P J, Monton C, Torres A. Relationship between ventilator-associated pneumonia and intramucosal gastric pHi: a case-control study. J Crit Care . 1996; 11 122-128
4 Luna C M, Vujacich P, Niederman M S. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest . 1997; 111 676-685
5 Niederman M. Bronchoscopy in non-resolving nosocomial pneumonia. Chest . 2000; 117(suppl) S121-S218
6 Lowenkron S, Niederman M S. Definition and evaluation of the resolution of nosocomial pneumonia. Semin Respir Infect . 1992; 7 271-281
7 Timsit J F, Chevret S, Valcke J. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Resp Crit Care Med . 1996; 154 116-123
8 Bregeon F, Papazian L, Visconti A, Gregoire R, Thirion X, Gouin F. Relationship of microbiologic diagnostic criteria to morbidity and mortality in patients with ventilator-associated pneumonia. JAMA . 1997; 277 655-662
9 Craven D E, Kunches L M, Kilinsky V. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis . 1986; 133 792-798
10 Celis R, Torres A, Gatell J M. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest . 1988; 93 318-324
11 Torres A, Aznar R, Gatell J M. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis . 1990; 142 523-528
12 Malangoni M, Crafton R, Mocek F C. Pneumonia in the surgical intensive care unit: factors determining successful outcome. Am J Surg . 1994; 167 250-255
13 Rello J, Ausina V, Ricart M. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest . 1993; 104 1230-1235
14 Kollef M H. Ventilator associated pneumonia: a multivariate analysis. JAMA . 1993; 270 1965-1970
15 Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest. . 1995; 107 511-516
16 Graybill J R, Marshall L W, Charache P. Nosocomial pneumonia: a continuing major problem. Am Rev Respir Dis . 1973; 108 1130-1140
17 Kollef M H, Silver P, Murphy D M, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest . 1995; 108 1655-1662
18 Kollef M H, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest . 1999; 115 462-474
19 American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis assessment of severity, initial antimicrobial therapy and preventative strategies: a consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med . 1996; 153 1711-1725
20 Rello J, Torres A, Ricart M. Ventilator-associated pneumonia by Staphylococcus aureus: comparision of methicillin-resistant and methicillin-sensitive episodes. Am J Resp Crit Care Med . 1994; 150 1545-1549
21 Bryan C S, Reynolds K L. Bacteremic nosocomial pneumonia: analysis of 172 episodes froma a single metropolitan area. Am Rev Respir Dis . 1984; 129 168-171
22 Fagon J Y, Chastre J, Hance A J, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med . 1993; 94 281-288
23 Rello J, Mariscal D, March F, Jubert P, Sanchez F, Valles J, Coll P. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection?. Am J Resp Crit Care Med . 1998; 157 912-916
24 Dennesen P J, van der Ven J A, Kessels A G, Ramsay G, Bonten M JM. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med . 2001; 163 1371-1375
25 Mosoni P, Langer M, Cigada M, Mandelli M. Epidemiology and risk factors of pneumonia in the critically ill patients. Eur J Epidemiol . 1991; 7 320-327
26 Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, Schiaffino-Cana S, Galvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med . 1994; 22 55-60
27 Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman M S. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa Clin Infect Dis . 1996; 23 973-978
28 Pittet D, Woolson R F, Wenzel R P. Microbiological factors influencing the outcome of nosocomial bloodstream infection: a 6-year, validated, population-based model. Clin Infect Dis . 1997; 24 1068-1078
29 Luna C, Videla A, Matera J. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia (VAP). Chest . 1999; 116 1075-1084
30 Leu H S, Kaiser D L, Mori M, Woolson R F, Wenzel R P. Hospital acquired pneumonia: atributable mortality and morbidity. Am J Epidemiol . 1989; 129 1258-1267
31 Joshi N, Localio A R, Hamory B. A predictive risk index for nosocomial pneumonia in the intensive care unit. Am J Med . 1992; 93 135-142
32 Chastre J, Vaugnat A, Joly-Guillou M L, Clavier H, Dombret M C, Gilbert C. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Resp Crit Care Med . 1998; 157 1165-1172
33 Baker A M, Meredith J W, Haponik E F. Pneumonia in intubated trauma patients: microbiology and outcomes. Am J Respir Crit Care Med . 1996; 153 343-349
34 Fagon J Y, Chastre J, Domart Y. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Am Rev Respir Dis . 1989; 139 877-884
35 Crouch Brewer S, Wunderink R G, Jones C B, Leeper Jr V K. Ventilator-associated pneumonia due to Pseudomonas aeruginosa Chest . 1996; 109 1019-1029
36 Prod'hom G, Leuenberger P, Koerfer J. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med . 1994; 120 653-662
37 Trouillet J L, Chastre J, Vuagnat A. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med . 1998; 157 531-539
38 Kollef M. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis . 2000; S131-S138
39 Vanhems P, Lepape A, Savey A. Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: risk factors and survival. J Hosp Infect . 2000; 45 98-106
40 Brunson M, Meduri G U, Leeper K V, Wunderink R G, Stanley T, Tolley E. Pneumonia in ARDS: diagnostic and prognostic value of bilateral bronchoscopic sampling [abstract]. Am Rev Respir Dis . 1993; 147 A355
41 Luna C M, Nogueira F, Videla A. Bronchoalveolar lavage (BAL) fluid quantitative culture and mortality in patients with severe pneumonia in the ICU [abstract]. Am J Respir Crit Care Med . 1998; 157 A695
42 Souweine B, Veber B, Bedos J P. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med . 1998; 26 236-244
43 Carmeli Y, Troillet N, Karchmer A W, Samore M H. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa Arch Intern Med . 1999; 159 1127-1132
44 Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group. Intensive Care Med . 1996; 387-394
45 Rello J, Gallego M, Mariscal D, Sonara R, Valles J. The role of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med . 1997; 156 196-200
46 Kollef M H, Ward S. The influence of mini-BAL cultures on patients outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest . 1998; 113 412-420
47 Sanchez-Nieto J M, Torres A, Garcia-Cordoba F. Impact of invasive versus invasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med . 1998; 157 371-376
48 Ruiz M, Torres A, Ewig S. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med . 2000; 162 119-125
49 Rello J, Ricart M, Ausina V, Net A, Prats G. Pneumonia due to Haemophilus influenzae among mechanically ventilated patients: incidence, outcome, and risk factors. Chest . 1992; 102 1562-1565
50 Niederman M S. The principles of antibiotic use and the selection of empiric therapy for pneumonia. In: Fishman A, ed. Pulmonary Diseases and Disorders 3rd ed. New York: McGraw-Hill 1997: 1939-1949
51 Hatala R, Dinh T, Cook D J. Once-daily aminoglycoside dosing in immunocompetent adults: a meta analysis. Ann Intern Med . 1996; 124 717-725
52 Hanes S D, Wood G C, Herring V. Intermittent and continuous ceftazidime infusion for critically ill trauma patients. Am J Surg . 2000; 179 436-440
53 Pugin J, Auckenthaler R, Mili N, Janssens J P, Lew P D, Suter P M. Diagnosis of ventilator-associated pneumonia by bacteriological analysis of bronchoscopic and nonbronchoscopic ``blind'' bronchoalveolar lavage fluid. Am Rev Respir Dis . 1991; 143 1121-1129
54 Garrard C S, A'Court C D. The diagnosis of pneumonia in the critically ill. Chest . 1995; 108(suppl) S17-S25
55 Singh N, Rogers P, Atwood C W, Wagener M M, Yu V L. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med . 2000; 162 505-511
56 Dreyfuss D, Mier L, Le Bordelles G. Clinical significance of borderline quantitative protected specimen culture results. Am Rev Respir Dis . 1993; 147 946-951
57 Montravers P, Fagon J Y, Chastre J. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis . 1993; 147 38-44
58 Luna C M, Blanzaco D, Niederman M. Resolution of ventilator-associated pneumonia: a prospective evaluation of early clinical predictors of outcome (in press). Crit Care Med . 2002;